CSL and Alentis announce global partnership to develop and commercialise lixudebart for rare kidney and liver diseases Alentis to receive US$355 million initial payment and up to US$1.2 billion… CISION PRNewswireOctober 5, 2026
PMET Signs Letter of Intent with Matagami for Spodumene Concentrate Transshipment to the Rail Network Letter of Intent ("LOI") advances a key component of the planned concentrate… CISION PRNewswireOctober 5, 2026
Press Release"Future Resonance — ShanghaiEye Night" Brings Shanghai to Washington, Fosters People-to-People Exchange Across the Pacific WASHINGTON, Oct. 4, 2026 /PRNewswire/ — On October 3, 2026, local time,… CISION PRNewswireOctober 4, 2026
Press ReleaseBlokees Debuts 90+ New Products at Wonder Festival Shanghai 2026 SHANGHAI, Oct. 4, 2026 /PRNewswire/ — From October 3 to 4, Assembly… CISION PRNewswireOctober 4, 2026
SIBIONICS and PharmaSens Explore New Horizons for Automated Insulin Delivery at EASD 2026 MILAN, Oct. 4, 2026 /PRNewswire/ — At the European Association for the Study… CISION PRNewswireOctober 4, 2026
Press ReleaseRoboParty Unveils RP1, a High-Performance Full-Stack Open-Source Humanoid Robot at IROS From RPO and Romomo to PartyOS, RoboParty is building an open humanoid… CISION PRNewswireOctober 3, 2026
Press ReleaseRoboParty Unveils RP1, a High-Performance Full-Stack Open-Source Humanoid Robot at IROS PITTSBURGH, Oct. 3, 2026 /PRNewswire/ — On September 28, 2026, RoboParty publicly unveiled… CISION PRNewswireOctober 3, 2026
Press Release'Global Civilization Dialogues' Series Arrives in Xi'an with Orchid Awards Guests XI’AN, China, Sept. 30, 2026 /PRNewswire/ — An international exchange event in… CISION PRNewswireOctober 3, 2026
